Casey Ager (@caseyager) profile picture

Assistant Professor at Mayo Clinic | Cancer Immunology

Scottsdale, AZ
Joined April 2016
Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)Photo by Casey Ager (@caseyager)
Congratulations to Dr. Casey Ager and his lab for their first R01 from the NCI! The 5-year grant is to study the role of TRPS1 in antitumor activity. This will hopefully lead to the discovery of a new therapeutic target for GU cancers and potentially other cancer types.
2
3
13
1,530
Excited to share our recent multi-center study showing PSMA+EVs are prognostic and predictive in oligometastatic prostate cancer treated with SBRT. Validation studies are ongoing. A future for EV-guided therapy! @MayoUrology @MayoRadOnc aacrjournals.org/clincancerr…
4
13
2
47
6,904
I’m pleased to finally share our latest paper. Due to recent personal loss, I was unable to share this earlier. Grateful for everyone’s support and understanding. Forever grateful to my collaborators and my mentor, @bizarMD, for his mentorship throughout this insightful journey.
Very excited to share new work from the lab dissecting mechanisms of liver-metastatic organotropism in melanoma and other cancers. Huge congrats to fearless post-doc @meri_rogava (on the job market!) who led this multi-year study! Below a brief summary... nature.com/articles/s43018-0…
4
4
17
3,020
#Tweetorial: Data from Drake Lab and others shows CSPC is immunologically different and not an ‘immune desert’ like CRPC. We interrogated CSPC metastases with single-cell RNA-seq (scRNA-seq), VIPER, and IF before and after tx w/ ADT +/- aPD-1 in a Phase 2 study. /1
Online Now: Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer dlvr.it/SyJRj4
10
34
5
89
34,313
Online Now: Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer dlvr.it/SyJRj4
1
49
1
175
53,492
We are hiring a Tech/Research assistant to work in our skin aging projects. Come join us in NYC opportunities.columbia.edu/j…
1
3
4
981
Post-doctoral fellow recruitment to NYC- WCM The Anandasabapathy lab in tissue and tumor immunology is seeking an organized, motivated, creative and enthusiastic scientist with excellent interpersonal and communication skills to join us! Reach out if you love T cells and DC too!
1
20
9
52
19,976
🚨Research technician position available! 🚨If you are recently graduated, looking for research experience in cancer biology and are responsible and motivated, please apply. Check us out at labs.icahn.mssm.edu/arriagal…. DM or email for details @TischCancer @IcahnMountSinai New York
1
9
1
16
2,817
Casey Ager retweeted
Busy day at #GU23. presented two novel immune therapy trials -CD28xPSMA bispecific antibody by Regeneron and a PSCA CAR-T by Bellicum - both studies had some subjects with deep PSA responses. Dawn of a new era of immune therapy in prostate cancer. @columbiacancer @ColumbiaMed
6
1
30
3,297
Seeking post-docs to study skin aging and cancer with a multidisciplinary approach. Come to dermatology at Columbia University in New York City 😊
5
11
1,644
The Spina Lab is hiring! Seeking post-docs to drive mechanistic study in a multiD fashion across oncology, immunology, genomics, systems biology, and radiation oncology in the preclinical & translational settings with industry partners for immediate translation. @columbiacancer
1
10
2
31
8,437
Excited to share our paper from @BizarMd and @elhamazizi labs at @Columbia just out in @NatureGenet. Thank you for the great collaboration Yiping Wang and @joy_lfan and fantastic leadership and mentorship by Ben and Elham!
1
4
22
3,443
Casey Ager retweeted
Excited to see our study on melanoma brain metastasis (MBM) published in @CellCellPress today. A massive team effort led by @_janabiermann and @JCA_Melms supported by many, outstanding collaborators. cell.com/cell/fulltext/S0092…
11
42
9
138
Excited to share our new study on the ecosystem of treatment-naïve melanoma brain metastasis (MBM) published in @CellCellPress today. A team effort from the Izar lab with @BizarMD @_janabiermann and many collaborators. cell.com/cell/fulltext/S0092…
6
58
264
Finally, our review on Myeloid Cell-targeted therapy is out in Nature Reviews Immunology!!! ⁦@PamSharmaMDPhD⁩ ⁦@DeblinaRC⁩ ⁦@swetha_anandhan⁩ ⁦@MDAndersonNews⁩ #womeninscience nature.com/articles/s41577-0…
4
48
4
162
Our pre-print on longitudinal scRNAseq of mCSPC mets (NCT03951831) is out! Moving needle w/ brilliant Aleks Obradovic, #bestmentors Chuck Drake, @drmnstein, & Andrea Califano. TY @ConquerCancerFd @theNCI @PCF_science @Regeneron!! Also @caseyager @columbiacancer
Single-Cell RNAseq Analysis Reveals Robust Anti-PD-1-Mediated Increase of Immune Infiltrate in Metastatic Castration-Sensitive Prostate Cancer biorxiv.org/cgi/content/shor… #bioRxiv
4
9
3
51
Another great talk yesterday as the Izar Lab (@bizarMD) delved into the biology of resistance to immunotherapy in melanoma. #AACR22
1
3
2
17
On our way to #AACR22 💫 NOLA we are coming ! @BizarMd lab 🎉@caseyager @triciahoho @lcaprio412 🎉🎉🎉